首页> 外文OA文献 >PGI25 Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

【2h】

PGI25 Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

机译：PGI25联合应用Peginterferon，利巴韦林和Boceprevir三联疗法在“现实生活”条件下治疗重度纤维化的慢性丙型肝炎病毒基因型1的成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ruiz-Antorán B.; Pascasio J.M.; Gea F.; Barcena R.; Larrubia J.; Pérez Álvarez R.; Sousa J.; Romero Gómez M.; Solá R.; de la Revilla. J.; Crespo J.; Navarro J.; Arenas J.; Delgado M.; Fernández Rodríguez C.; Planas R; Buti M.; Forns X.; Calleja J.L.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis [J] . Calleja Jose L., Pascasio Juan M., Ruiz-Antoran Belen, Liver international : . 2015,第1期

机译：在患有严重肝纤维化的丙型肝炎西班牙基因西班牙患者的早期治疗方案中，使用聚乙二醇干扰素，利巴韦林和博西泼韦三联疗法的安全性和有效性：SVRw12分析
2. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection [J] . SaabS., GordonS.C., ParkH., Alimentary pharmacology & therapeutics. . 2014,第6期

机译：索非布韦联合聚乙二醇干扰素/利巴韦林治疗慢性丙型肝炎病毒基因型1感染的成本效益分析
3. Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy. [J] . Itoh Y, Nishimura T, Yamaguchi K, Hepatology research: the official journal of the Japan Society of Hepatology . 2011,第12期

机译：感染基因型2的慢性丙型肝炎患者的肝脂肪变性与胰岛素抵抗，肝纤维化有关，并影响聚乙二醇干扰素联合利巴韦林联合治疗的血清丙型肝炎病毒RNA的累积阳性。
4. EFFICIENCY OF VIBRO-ACOUSTICAL METHOD OF THERAPY FOR CHRONIC VIRUS HEPATITIS TREATMENT [C] . Kovelenov A. Yu., Obrezan A. G., Fiodorov V. A. International Congress on Sound and Vibration . 2003

机译：慢性病毒肝炎治疗慢性疗法培养方法的效率
5. Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study [O] . Alessandra Mangia, Graham R. Foster, Christoph P. Berg, 2017

机译：基于boceprevir或telaprevir的三联疗法或双重peginterferon alfa-2a或alfa-2b联合利巴韦林疗法在慢性丙型肝炎中的疗效和安全性：现实世界中的PegBase观察性研究
6. Cost-Effectiveness Analysis of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions [O] . B. Ruiz-Antorán, J.M. Pascasio, J. de la Revilla, 2015

机译：PEGINTERFERON，利巴韦林和BOICEPREVIR对慢性丙型肝炎病毒基因型1治疗慢性丙基肝炎病毒基因型1的成本效果分析

PGI25 Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

著录项

引文网络

相似文献

相关主题

期刊订阅